Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Other financing activities (2021)

Serina Therapeutics' Other financing activities history spans 1 years, with the latest figure at -$250000.0 for Q1 2021.

  • For Q1 2021, Other financing activities changed N/A year-over-year to -$250000.0; the TTM value through Dec 2021 reached -$250000.0, changed N/A, while the annual FY2021 figure was -$250000.0, 259.24% down from the prior year.
  • Other financing activities for Q1 2021 was -$250000.0 at Serina Therapeutics.
  • Across five years, Other financing activities topped out at -$250000.0 in Q1 2021 and bottomed at -$250000.0 in Q1 2021.